Robert F. Williamson III - 12 Nov 2025 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Reporting relationship: Director
Issuer ticker: CATX
Reported as of: 12 Nov 2025
Net transaction value: +$19,946
SEC form: 4
Accepted by SEC: 14 Nov 2025, 08:00:03 UTC
Prior SEC filing: 01 Apr 2025
Next SEC filing: 04 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Robert F. Williamson, III by Chris Nenno, as Attorney-in-Fact

Key filing fact

Robert F. Williamson III filed Form 4 for Perspective Therapeutics, Inc. (CATX) on 14 Nov 2025.

Key facts

This page summarizes Robert F. Williamson III's Form 4 filing for Perspective Therapeutics, Inc. (CATX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Nov 2025, 08:00.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001397331 Primary reporting owner

Relationship: Director
Address: C/O PERSPECTIVE THERAPEUTICS, INC., 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE
Signature: /s/ Robert F. Williamson, III by Chris Nenno, as Attorney-in-Fact
Signature date: 14 Nov 2025

Shares, units, or other non-derivative securities reported in this filing.

CATX transaction

Purchase

CATX holding

No transaction description listed

^* marks a reported price that did not pass the local price check.